Description of Collaborative Activity: |
This behavioral research study is evaluating whether non-daily medication regimens for HIV Pre-Exposure Prophylaxis (PrEP) may be more acceptable and foster better adherence to treatment. PrEP represents a novel biomedical approach to HIV prevention in which individuals at-risk for HIV take antiretroviral medications to help prevent HIV infection. The HPTN 067 study is conducted through the HIV Prevention Trials Network led by the National Institute of Allergy and Infectious Diseases (NIAID). An interagency agreement between the National Institute of Mental Health (NIMH) and the Centers for Disease Control and Prevention (CDC) supports the implementation of this international study at a clinical research site in Bangkok, Thailand. |
